BAROZZI, Patrizia
 Distribuzione geografica
Continente #
NA - Nord America 19.465
EU - Europa 8.630
AS - Asia 7.726
SA - Sud America 1.015
AF - Africa 183
Continente sconosciuto - Info sul continente non disponibili 21
OC - Oceania 9
Totale 37.049
Nazione #
US - Stati Uniti d'America 19.207
GB - Regno Unito 3.102
CN - Cina 2.231
SG - Singapore 2.204
IT - Italia 1.575
HK - Hong Kong 1.059
SE - Svezia 913
VN - Vietnam 821
BR - Brasile 767
DE - Germania 670
FI - Finlandia 587
UA - Ucraina 398
RU - Federazione Russa 396
FR - Francia 353
TR - Turchia 328
KR - Corea 221
IN - India 219
BG - Bulgaria 153
CA - Canada 120
NL - Olanda 102
ID - Indonesia 95
BD - Bangladesh 94
AR - Argentina 82
MX - Messico 73
JP - Giappone 63
IQ - Iraq 57
BE - Belgio 49
ZA - Sudafrica 48
PL - Polonia 45
ES - Italia 43
AE - Emirati Arabi Uniti 42
CZ - Repubblica Ceca 40
EC - Ecuador 39
IE - Irlanda 39
IR - Iran 38
CO - Colombia 36
PK - Pakistan 31
CL - Cile 30
AT - Austria 29
PH - Filippine 29
BZ - Belize 26
LT - Lituania 26
MA - Marocco 24
VE - Venezuela 22
AZ - Azerbaigian 21
UZ - Uzbekistan 21
KE - Kenya 20
MY - Malesia 20
EG - Egitto 18
RO - Romania 18
DZ - Algeria 16
EU - Europa 16
PY - Paraguay 16
TN - Tunisia 16
SA - Arabia Saudita 15
JO - Giordania 14
NP - Nepal 12
CY - Cipro 11
CH - Svizzera 9
DK - Danimarca 9
IL - Israele 9
SK - Slovacchia (Repubblica Slovacca) 9
TH - Thailandia 9
TW - Taiwan 9
UY - Uruguay 9
AL - Albania 8
AU - Australia 8
ET - Etiopia 8
JM - Giamaica 8
PT - Portogallo 8
PE - Perù 7
PS - Palestinian Territory 7
RS - Serbia 7
BO - Bolivia 6
CR - Costa Rica 6
GR - Grecia 6
KZ - Kazakistan 6
DO - Repubblica Dominicana 5
EE - Estonia 5
KG - Kirghizistan 5
MD - Moldavia 5
NG - Nigeria 5
NI - Nicaragua 5
OM - Oman 5
PA - Panama 5
QA - Qatar 5
SY - Repubblica araba siriana 5
BY - Bielorussia 4
LB - Libano 4
LV - Lettonia 4
SI - Slovenia 4
AM - Armenia 3
BA - Bosnia-Erzegovina 3
BH - Bahrain 3
BN - Brunei Darussalam 3
HU - Ungheria 3
MK - Macedonia 3
SN - Senegal 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AO - Angola 2
Totale 36.999
Città #
Southend 2.310
Fairfield 1.978
Ashburn 1.773
Santa Clara 1.572
Singapore 1.417
Woodbridge 1.279
Hong Kong 1.047
Chandler 955
Houston 954
Ann Arbor 820
Jacksonville 783
Hefei 771
Seattle 738
Wilmington 696
Dearborn 655
Cambridge 589
San Jose 521
Nyköping 504
Helsinki 417
London 380
Beijing 375
Chicago 360
Los Angeles 356
Modena 296
New York 286
Ho Chi Minh City 273
The Dalles 261
Seoul 202
Izmir 190
Hanoi 178
Council Bluffs 169
San Diego 163
Buffalo 159
Princeton 149
Sofia 149
Eugene 139
Salt Lake City 127
Lauterbourg 119
Milan 110
Moscow 107
Munich 107
Dallas 103
Fremont 89
Shanghai 76
São Paulo 74
Rome 72
Bremen 71
Des Moines 70
Tampa 61
Bologna 58
Columbus 57
Elk Grove Village 57
Jakarta 54
Orem 54
Boardman 53
Tokyo 51
Frankfurt am Main 50
Redwood City 48
Atlanta 44
Da Nang 42
Brussels 40
Haiphong 39
Dublin 37
Philadelphia 37
Brooklyn 35
Chennai 34
Montreal 33
Albuquerque 32
Boston 32
Toronto 31
Turku 31
Phoenix 30
Lancaster 29
Denver 27
Johannesburg 27
Kent 27
Warsaw 27
Belize City 26
Las Vegas 26
Ottawa 26
Paris 25
Rio de Janeiro 25
Stockholm 24
Guangzhou 23
Nanjing 23
Baghdad 22
Norwalk 22
Amsterdam 21
Leawood 21
Miami 21
Sterling 21
Verona 21
Dulles 20
Kunming 20
Reggio Emilia 20
San Mateo 20
Tashkent 20
Jinan 19
Manchester 19
Mexico City 19
Totale 26.670
Nome #
HHV-6A in syncytial giant-cell hepatitis 459
Changes in T-Cell Responses Against Human Herpesvirus-8 Correlate with the Disease Course of Iatrogenic Kaposi's Sarcoma in a Patient with Undifferentiated Arthritis 441
Feedbacks and adaptive capabilities of the PI3K/Akt/mTOR axis in acute myeloid leukemia revealed by pathway selective inhibition and phosphoproteome analysis 436
Characterization of Specific Immune Responses to Different Aspergillus Antigens during the Course of Invasive Aspergillosis in Hematologic Patients 415
Lack of confirmation of an association between HTLV-I infection and myelodysplastic syndrome 406
Epidemiology and clinical outcome of lower respiratory tract infections by respiratory syncytial virus or parainfluenza virus type 3 in adults receiving treatment for either acute leukemia or severe aplastic anemia: a retrospective single center study 395
BCR-ABL-specific T-cell therapy in Ph+ ALL patients on tyrosine-kinase inhibitors 390
B cells and herpesviruses: a model of lymphoproliferation 390
Bone marrow failure associated with human herpesvirus 8 infection after transplantation 363
NPM1 mutations may reveal acute myeloid leukemia in cases otherwise morphologically diagnosed as myelodysplastic syndromes or myelodysplastic/myeloproliferative neoplasms 360
Acute myeloid leukemia in patients living with HIV infection: Several questions, fewer answers 353
Human herpesvirus-8 DNA sequences in Human Immunodeficiency Virus-negative angioimmunoblastic lymphadenopathy and benign lymphadenopathy with giant germinal center hyperplasia and increased vascularity 352
Acute appendicitis in adult neutropenic patients with hematologic malignancies 351
Post-transplant Kaposi sarcoma originates from the seeding of donor-derived progenitors 351
PCR con primer degenerati non evidenzia sequenze virali di HHV-8 ne di una sua variante in cellule stromali midollari di pazienti affetti da gammopatie monoclonali 349
A case of JAK2 V617F-positive myelodysplastic/myeloproliferative neoplasm with unusual morphology, resembling acute promyelocytic leukemia-like disorder with a chronic course. 348
Emergence of BCR-ABL-specific cytotoxic T cells in the bone marrow of patients with Ph+ acute lymphoblastic leukemia during long-term Imatinib mesylate treatment. 347
Complessazione di SiRNA anti Blimp-1/PRDM con liposomi cationici: caratterizzazione chimico-fisica e validazione in vitro su cellule di PEL 343
PEGylated siRNA lipoplexes for silencing of BLIMP-1 in Primary Effusion Lymphoma: In vitro evidences of antitumoral activity 341
Assessment of aspergillus-specific T cells for diagnosis of invasive aspergillosis in a leukemic child with liver lesions mimicking hepatosplenic candidiasis 340
Characterization and dynamics of specific T cells against nucleophosmin-1 (NPM1)-mutated peptides in patients with NPM1-mutated acute myeloid leukemia 340
Detection of Fusarium-specific T cells in hematologic patients with invasive fusariosis 338
Antineoplastic effects of liposomal siRNA treatment targeting BLIMP1/PRDM1 in primary effusion lymphoma 337
Cidofovir-loaded liposomes: an intro-study using BCBL-1 cell line as a model for primary effusion lymphoma 336
Translational challenges of human herpesvirus 6 chromosomal integration. 336
Novel polymeric/lipidic hybrid systems (PLHs) for effective Cidofovir delivery: preparation, characterization and comparative in vitro study with polymeric particles and liposomes 336
Changes in the immune responses against human herpesvirus-8 in the disease course of posttransplant Kaposi sarcoma 333
Effectiveness of originator (Neupogen) and biosimilar (Zarzio) filgrastim in autologous peripheral blood stem cell mobilization in adults with acute myeloid leukemia: a single-center retrospective study 332
Mucorales-specific T cells in patients with hematologic malignancies 324
Diagnosis of invasive aspergillosis by tracking Aspergillus-specific T cells in hematologic patients with pulmonary infiltrates 320
Pathogenetic mechanisms of hepatitis C virus-induced B-cell lymphomagenesis. 315
Atraumatic splenic rupture in patients with myelodysplastic syndromes: Report of a case occurred during treatment with 5-azacitidine and review of the literature. 315
Chronic eosinophilic leukaemia with ETV6-NTRK3 fusion transcript in an elderly patient affected with pancreatic carcinoma 314
Dual inhibition of PI3K/mTOR signaling in chemoresistant AMLprimary cells. 311
Human herpesvirus 6 latency characterized by high viral load: Chromosomal integration in many, but not all, cells 307
Organising pneumonia mimicking invasive fungal disease in patients with leukaemia. 305
Angiogenesis in multiple myeloma: Correlation between in vitro endothelial colony growth (CFU-En) and clinical biological features 305
All-trans retinoic acid (ATRA) in non-promyelocytic acute myeloid leukemia (AML): results of combination of ATRA with low-dose Ara-C in three elderly patients with NPM1-mutated AML unfit for intensive chemotherapy and review of the literature 304
Immunoglobulin gene mutations and frequent use of VH1-69 and VH4-34 segments in hepatitis C virus-positive and hepatitis C virus-negative nodal marginal zone B-cell lymphoma 302
Chronic/relapsing lymphadenopathy associated with HHV-6B infection: a new benign clinico-pathologic entity occurring in immunocompetent individuals 301
Parvoviruses in blood donors and transplant patients, Italy 298
The bone marrow represents an enrichment site of specific T lymphocytes against filamentous fungi 298
Chronic and recurrent benign lymphadenopathy without constitutional symptoms associated with human herpesvirus-6B reactivation 294
BCR-ABL-specific cytotoxic T cells in the bone marrow of patients with Ph(+) acute lymphoblastic leukemia during second-generation tyrosine-kinase inhibitor therapy. 291
3 CASES OF HUMAN HERPESVIRUS-6 LATENT INFECTION - INTEGRATION OF VIRAL GENOME IN PERIPHERAL-BLOOD MONONUCLEAR CELL-DNA 287
Severe pancytopenia and hemophagocytosis after HHV-8 primary infection in a renal transplant patient successfully treated with foscarnet 286
Human Herpesvirus 8 (HHV8) Infection and Related Diseases in Italian Transplant Cohorts. 285
Epstein-Barr virusassociated pneumonia in an adult patient with severe aplastic anaemia: resolutionafter the transient withdrawal of cyclosporine. 283
Circulating functional T cells specific to human herpes virus 6 (HHV6) antigens in individuals with chromosomally integrated HHV6 280
Diagnosis of aspergillosis: Role of proteomics 278
Additional neoplasms and HCV infection in low-grade lymphoma of MALT type 274
HHV-6 and atypical lymphoproliferative disorders: are only qualitative molecular examinations sufficient to support a pathogenetic role? 274
Epidemiology and clinical outcomes of latent tuberculosis infection in adults affected with acute leukemia or aplastic anemia: a retrospective single-center study 273
Treatment of herpesvirus associated primary effusion lymphoma with intracavity cidofovir 270
May the indirect effects of CIHHV-6 in transplant patients be exerted through the reactivation of the viral replicative machinery? 270
Common vascular endothelial growth factor variants and risk for posttransplant Kaposi sarcoma. 269
"Metodo per la diagnosi e/o il monitoraggio della mucormicosi" - "Method for the diagnosis of and/or monitoring mucormycosis" 267
Targeted integration of human herpesvirus 6 in the p arm of chromosome 17 of human peripheral blood mononuclear cells in vivo 267
Multicenter Prospective Study for Laboratory Diagnosis of HHV8 Infection in Solid Organ Donors and Transplant Recipients and Evaluation of the Clinical Impact After Transplantation 265
Identification and characterization of Aspergillus-specific immune responses to diagnose invasive aspergillosis in high risk patients: a multicenter study 262
Successful Treatment of KSHV Inflammatory Cytokine Syndrome (KICS) after Kidney-Liver Transplant: Correlations with HHV8 miRNome and Specific T-Cell Response 260
Long-term molecular remission with persistence of BCR-ABL1-specific cytotoxic T cells following imatinib withdrawal in an elderly patient with Philadelphia-positive ALL 259
Indirect Antitumor Effects of Mammalian Target of Rapamycin Inhibitors Against Kaposi Sarcoma in Transplant Patients 258
Prevalence of Human Herpesvirus-6 Chromosomal Integration (CIHHV-6) in Italian Solid Organ and Allogeneic Stem Cell Transplant Patients 257
BK virus infection and neurologic dysfunctions in a patient with lymphoma treated with chemotherapy and rituximab 256
Mucorles-specific T cells emerge in the course of invasive mucormucosis and may be used as a surrogate diagnostic marker in high-risk patients 256
Veicolazione liposomiale del cidofovir nel trattamento del PEL (Primary Effusion Lynphoma) 254
Late-appearing PML/RAR alpha fusion transcript with coincidental t(12;13)(p13.2;q14) in acute promyelocytic leukemia lacking the t(15;17) cytogenetic anomaly 250
How I treat HHV8/KSHV-related diseases in posttransplant patients. 247
Human herpesvirus-8 infection in hemodialysis patients from northern Italy. 245
siRNA-BASED THERAPEUTICS: DELIVERY AND TARGETING TO PEL TUMOR BY USING CATIONIC LIPOSOMES 245
The oncogenic 30 and 69 bp deletion variants of the EBV LMP-1 gene are common in HIV-negative lymphoproliferations, both malignant and benign 245
HHV-8-associated primary cerebral B-cell lymphoma in HIV-negative patient after long-term steroids 244
Cellular localization of human herpesvirus 8 in nonneoplastic lymphadenopathies and chronic interstitial pneumonitis by in situ polymerase chain reaction studies 243
Splenic hyalohyphomycosis, molecularly and immunologically consistent with invasive aspergillosis, in a patient with acute lymphoblastic leukemia. 242
HHV-8 infection in the transplantation setting: A concern only for solid organ transplant patients? 242
BTK Inhibition Impairs the Innate Response Against Fungal Infection in Patients With Chronic Lymphocytic Leukemia 241
Nanosistemi lipidici targettizzati per il direzionamento di siRNA con attività antineoplastica al linfoma primitivo delle cavità sierose (PEL) 239
Molecular evidence of organ-related transmission of Kaposi sarcoma-associated herpesvirus or human herpesvirus-8 in transplant patients 238
HUMAN HERPESVIRUS-6 - A SURVEY OF PRESENCE AND DISTRIBUTION OF GENOMIC SEQUENCES IN NORMAL BRAIN AND NEUROGLIAL TUMORS 238
Tumor-targeted immunoliposomal nanosystems to deliver either Cidofovir or Antineoplastic SiRNA against Primary Effusion Lymphoma (PEL) 237
Detection of antibodies to human herpesvirus 8 in Italian children: evidence for horizontal transmission 234
Human herpesvirus 8-associated diseases in solid-organ transplantation: importance of viral transmission from the donor 234
Metodo per la diagnosi e/o il monitoraggio dell’ aspergillosi invasiva 233
LIPOPLEXES PER LA VEICOLAZIONE ED IL DIREZIONAMENTO DI siRNA AL PEL: VALUTAZIONE DELL’EFFICIENZA DI TRATTAMENTO CON SISTEMI LIPIDICI STABILIZZATI 228
Human herpesvirus-6 (HHV-6) in blood donors 227
Kaposi's sarcoma triggered by endogenous HHV-8 reactivation after non-myeloablative allogeneic haematopoietic transplantation 226
Clinico-pathological characterization of hepatitis C virus-related B-cell non-Hodgkin's lymphomas without symptomatic cryoglobulinemia 224
Polymerase chain reaction detection of human herpesvirus 8 sequences in primary central nervous system lymphomas 223
Human herpesvirus 6 infection in normal human brain tissue 221
Interferon-alpha may restore sensitivity to tyrosine-kinase inhibitors in Philadelphia chromosome positive acute lymphoblastic leukaemia with F317L mutation 220
CHARACTERIZATION OF HUMAN HERPESVIRUS-6 GENOMES FROM CASES OF LATENT INFECTION IN HUMAN LYMPHOMAS AND IMMUNE DISORDERS 215
Immunoliposomal systems targeting the primary effusion lymphoma (PEL): in vitro study 215
Lymphotropic herpes virus (EBV, HHV-6, HHV-8) DNA sequences in HIV negative Castleman's disease 214
Is it now the time to update treatment protocols for lymphomas with new anti-virus systems? 207
Fatal hemophagocytic syndrome related to active human herpesvirus-8/Kaposi sarcoma-associated herpesvirus infection in human immunodeficiency virus-negative, non-transplant patients without related malignancies 206
Human herpesvirus-6 reactivation in a longitudinal study of two HIV-1 infected patients 205
Differences in Kaposi sarcoma-associated herpesvirus-specific and herpesvirus-non-specific immune responses in classic Kaposi sarcoma cases and matched controls in Sicily. 204
Spontaneous loss of Ph chromosome with maintenance of clonal hemopoiesis in an untreated patient with myeloproliferative disease and a long survival. 202
Prognostic Relevance of Multi-Antigenic Myeloma-Specific T-Cell Assay in Patients with Monoclonal Gammopathies 201
Totale 28.847
Categoria #
all - tutte 137.596
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 137.596


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021867 0 0 0 0 0 0 0 0 0 450 223 194
2021/20222.760 76 381 381 171 57 98 181 136 264 189 505 321
2022/20232.915 391 322 173 284 429 388 75 277 298 36 148 94
2023/20241.938 66 110 137 167 410 206 218 284 35 38 85 182
2024/20255.820 248 71 101 426 1.053 832 454 324 609 240 617 845
2025/202610.090 814 507 1.072 1.219 1.812 877 1.346 564 1.110 769 0 0
Totale 37.338